Performance of BioFire array or QuickVue influenza A + B test versus a validation qPCR assay for detection of influenza A during a volunteer A/California/2009/H1N1 challenge study

Not checked yet

• Both supplementary workbooks, original main/correction layouts, clipped raster-border glyphs, raw assay/clinical records, repositories and code remain unread or unreceived. A gel band alone does not establish sequence identity or uncropped provenance. No raw patient records, source formulas or scientific code were collected or executed.
• 351 BioFire and299 rapid-test comparisons are repeated matched-swab pairs rather than independent participants. Separate sets, prevalence, timing and comparator assumptions limit interpretation. qPCR accuracy was assumed; it is not independently established for every sample. The printed sensitivity confidence interval ends at79.5% in the abstract and79.4% elsewhere. Community generalization and predictive values are not inferred.
• The correction repairs a typesetting denominator while retaining the individual counts; it does not reproduce or validate the whole study. Nolan is not the stated primary operator, analyst or manuscript writer. Funding/affiliation does not establish secret-programme access or UAP evidence. No present-day clinical advice or product recommendation follows.